{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:644073",
      "entity_text" : "buprenorphine",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02272",
      "entity_text" : "kappa-opioid receptor",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "An alternative, but not mutually exclusive, explanation is that the buprenorphine : samidorphan combination is acting as a functional kappa-opioid receptor antagonist as the intrinsic kappa-opioid receptor antagonism of buprenorphine is unaffected by samidorphan.",
  "reading_complete" : "2020-08-08T12:33:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T12:24:22Z",
  "trigger" : "antagonism",
  "evidence" : [ "kappa-opioid receptor antagonism of buprenorphine" ],
  "pmc_id" : "6310672",
  "score" : 0
}